ID: ALA173129

Max Phase: Preclinical

Molecular Formula: C13H13NO4

Molecular Weight: 247.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)OC(=O)N1C(=O)C(=O)c2ccccc21

Standard InChI:  InChI=1S/C13H13NO4/c1-13(2,3)18-12(17)14-9-7-5-4-6-8(9)10(15)11(14)16/h4-7H,1-3H3

Standard InChI Key:  ASIDXWXJMMEZHR-UHFFFAOYSA-N

Associated Targets(Human)

Beta-chymotrypsin 261 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 247.25Molecular Weight (Monoisotopic): 247.0845AlogP: 2.15#Rotatable Bonds: 0
Polar Surface Area: 63.68Molecular Species: HBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.25CX LogD: 2.25
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.66Np Likeness Score: -0.34

References

1. Iyer RA, Hanna PE.  (1995)  N-(carbobenzyloxy)isatin: A slow binding -keto lactam inhibitor of -chymotrypsin,  (1): [10.1016/0960-894X(94)00464-Q]

Source